{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-10",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20201023",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "65030",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/210557Orig1s002ltr.pdf",
              "date": "20201027",
              "type": "Letter"
            },
            {
              "id": "65041",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/210557s002lbl.pdf",
              "date": "20201027",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20190621",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 1",
          "submission_class_code_description": "Type 1 - New Molecular Entity",
          "application_docs": [
            {
              "id": "59159",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2019/210557s000lbl.pdf",
              "date": "20190621",
              "type": "Label"
            },
            {
              "id": "59164",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/210557Orig1s000ltr.pdf",
              "date": "20190802",
              "type": "Letter"
            },
            {
              "id": "59579",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2019/210557Orig1s000TOC.html",
              "date": "20190806",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "NDA210557",
      "sponsor_name": "COSETTE",
      "openfda": {
        "application_number": [
          "NDA210557"
        ],
        "brand_name": [
          "VYLEESI"
        ],
        "generic_name": [
          "BREMELANOTIDE"
        ],
        "manufacturer_name": [
          "Cosette Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "0713-0897"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "BREMELANOTIDE ACETATE"
        ],
        "rxcui": [
          "2176316",
          "2176321"
        ],
        "spl_id": [
          "437e6c45-dfb9-35ec-e063-6394a90a7874"
        ],
        "spl_set_id": [
          "f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf"
        ],
        "package_ndc": [
          "0713-0897-06",
          "0713-0897-04"
        ],
        "unii": [
          "PV2WI7495P"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "VYLEESI (AUTOINJECTOR)",
          "active_ingredients": [
            {
              "name": "BREMELANOTIDE ACETATE",
              "strength": "EQ 1.75MG BASE/0.3ML (EQ 1.75MG BASE/0.3 ML)"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "SOLUTION",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}